NASDAQ · IBRX
ImmunityBio, Inc.
$8.74-$0.07 (-0.79%)
ImmunityBio, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.69% below the high.
Loading market information…
NYSE · BKD · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Brookdale Senior Living Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.91% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Brookdale Senior Living Inc.’s forward annual dividend is $1.00 per share, paid quarterly. The forward yield is 9.74% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Brookdale Senior Living Inc.’s next earnings report is currently expected on Nov 6, 2026, with estimated earnings per share of -$0.03. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Brookdale Senior Living Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Brookdale Senior Living Inc., founded in 2005 and based in Brentwood, Tennessee, specializes in the ownership, operation, and management of senior residential communities across the United States. Its services are structured into three distinct divisions. The Independent Living division oversees properties that integrate both independent and assisted living units within a single community, primarily serving middle to upper-income seniors. The Assisted Living and Memory Care segment provides residential solutions through both multi-story and single-story properties, offering housing alongside 24-hour assistance with daily activities for residents. This segment also includes specialized memory care facilities for individuals living with Alzheimer's disease and other forms of dementia. Lastly, the Continuing Care Retirement Communities (CCRCs) segment features properties that offer a comprehensive range of living options, including independent living, assisted living, memory care, and skilled nursing, designed to accommodate varying levels of physical ability and healthcare requirements. In addition to its proprietary portfolio, Brookdale also manages senior living communities on behalf of external clients. As of December 31, 2021, the company's extensive network included 347 owned communities, 299 leased facilities, and 33 communities managed for other organizations.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 6, 2025 | -$0.28-154.55% vs estimate | $813.86M-0.37% vs estimate |
|---|
| Q4 2024 | Feb 18, 2025 | -$0.37-131.25% vs estimate | $780.95M-0.11% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | -$0.22-29.41% vs estimate | $784.17M-0.01% vs estimate |
|---|
THE ANALYST VIEW
12 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 2 contributors · Median target $19.50.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$8.74-$0.07 (-0.79%)
ImmunityBio, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.69% below the high.
$31.96-$0.27 (-0.84%)
Cogent Biosciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 26.92% below the high.
$212.16+$0.37 (+0.17%)
National HealthCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.52% below the high.
$19.32+$0.03 (+0.16%)
Denali Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
$13.26+$0.20 (+1.53%)
Aveanna Healthcare Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.86% below the high.
$29.46-$0.05 (-0.17%)
Acadia Healthcare Company, Inc.’s quoted price sits in the upper half of its reported 52-week range, 17.78% below the high.
$18.61+$0.22 (+1.2%)
Arcus Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.37% below the high.
$124.34+$2.16 (+1.77%)
Addus HomeCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.92% below the high.
